Organigram has reported their 1st Quarter 2016 results, the announcement can be found here.
Positive news for one of my two Medical Marijuana holdings. They hit positive cash flow from operations, and have exceeded their previously announced goals (which had also been increased over previous expectations).
Canada's Medical Marijuana space is fairly crowded, however I tried to pick two holdings that could prosper even if, for some reason, the planned legalization of marijuana for recreational doesn't go through, or goes through in a form that isn't beneficial to the medical companies. Organigram benefits by being the only major, active supplier east of Ottawa, offering fully bilingual services, and having product strains that are organic certified.